GSTTX
Price
$11.33
Change
+$0.03 (+0.27%)
Updated
Apr 17 closing price
Net Assets
162.86M
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

GSTTX vs VIGRX

Header iconGSTTX vs VIGRX Comparison
Open Charts GSTTX vs VIGRXBanner chart's image
Goldman Sachs Strategic Growth I
Price$11.33
Change+$0.03 (+0.27%)
VolumeN/A
Net Assets162.86M
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
GSTTX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSTTX vs. VIGRX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSTTX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. GSTTX (163M). VIGRX pays higher dividends than GSTTX: VIGRX (0.39) vs GSTTX (0.00). GSTTX was incepted earlier than VIGRX: GSTTX (16 years) vs VIGRX (32 years). GSTTX (1.07) is less costly to investors than VIGRX (0.17). GSTTX is a more actively managed with annual turnover of: 39.00 vs. VIGRX (5.00). GSTTX has a lower initial minimum investment than VIGRX: GSTTX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. GSTTX (0.18). VIGRX return over 5 years is better than : 99.21 vs. GSTTX (19.96).
GSTTXVIGRXGSTTX / VIGRX
Total Expense Ratio0.780.17459%
Annual Report Gross Expense Ratio1.070.17629%
Fund Existence16 years32 years-
Gain YTD-15.546-14.326109%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets163M261B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year0.186.013%
Returns for 3 years3.2030.3311%
Returns for 5 years19.9699.2120%
Returns for 10 years-12.96223.84-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics